Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease

Jørgensen, Anders Berg, Frikke-Schmidt, Ruth, Nordestgaard, Børge G., Tybjærg-Hansen, Anne·2014·New England Journal of Medicine

DOI 10.1056/nejmoa1308027

Cited by (923)

Items 101–200 of 923

There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness
Michael E. Makover, Michael David Shapiro, Peter Paul Toth · 2022 · American Journal of Preventive Cardiology
Increased Risk for Other Cancers in Addition to Breast Cancer for CHEK2*1100delC Heterozygotes Estimated From the Copenhagen General Population Study
Charlotte Näslund‐Koch, Børge Grønne Nordestgaard, Stig E. Bojesen · 2016 · Journal of Clinical Oncology
Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study
Kaltoft, Morten, Langsted, Anne, Nordestgaard, Børge G · 2020 · European Heart Journal
Shared Risk Factors between Dementia and Atherosclerotic Cardiovascular Disease
Liv Tybjærg Nordestgaard, Mette Christoffersen, Ruth Frikke‐Schmidt · 2022 · International Journal of Molecular Sciences
Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity
Zhao, Yimin, Zhuang, Zhenhuang, Li, Yueying, Xiao, Wendi, Song, Zimin, Huang, Ninghao, Wang, Wenxiu, Dong, Xue, Jia, Jinzhu, Clarke, Robert et al. · 2024 · Nature Communications
High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real‐World Administrative Claims Analysis of Statin‐Treated Patients With High Residual Cardiovascular Risk
Toth, Peter P., Granowitz, Craig, Hull, Michael, Liassou, Djibril, Anderson, Amy, Philip, Sephy · 2018 · Journal of the American Heart Association
Apolipoprotein C-III
Alison B. Kohan · 2015 · Current Opinion in Endocrinology Diabetes and Obesity
Exome-wide association analysis reveals novel coding sequence variants associated with lipid traits in Chinese
Clara Sze-Man Tang, He Zhang, Chloe Y. Y. Cheung, Ming Xu, Jenny Chung-Yee Ho, Wei Zhou, Stacey Shawn Cherny, Yan Zhang, Oddgeir L. Holmen, Ka‐Wing Au et al. · 2015 · Nature Communications
APOC3 Loss-of-Function Mutations, Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular Risk
Anders Berg Wulff, Børge Grønne Nordestgaard, Anne Tybjærg‐Hansen · 2018 · Arteriosclerosis Thrombosis and Vascular Biology
Genetics of Triglycerides and the Risk of Atherosclerosis
Jacqueline S. Dron, Robert Alexander Hegele · 2017 · Current Atherosclerosis Reports
The Role of Lipids and Lipoproteins in Atherosclerosis
MacRae F. Linton, Patricia G. Yancey, Sean S. Davies, W. Gray Jerome, Edward F. Linton, Wen‐Liang Song, Amanda C. Doran, Kasey C. Vickers · 2015 · Europe PMC (PubMed Central)
A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels
Sumeet A. Khetarpal, Xuemei Zeng, John S. Millar, Cecilia Vitali, Amritha Varshini Hanasoge Somasundara, Paolo Zanoni, James A. Landro, Nicole Barucci, William J. Zavadoski, Zhiyuan Sun et al. · 2017 · Nature Medicine
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Michaeli, Daniel Tobias, Michaeli, Julia Caroline, Albers, Sebastian, Boch, Tobias, Michaeli, Thomas · 2023 · American Journal of Cardiovascular Drugs
Triglycerides and risk of atherosclerotic cardiovascular disease: An update
Michel Farnier, Marianne Zeller, David Masson, Yves Cottin · 2021 · Archives of cardiovascular diseases
Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes
Jenny E. Kanter, Baohai Shao, Farah Kramer, Shelley Barnhart, Masami Shimizu‐Albergine, Tomáš Vaisar, Mark J. Graham, Rosanne M. Crooke, Clarence R. Manuel, Rebecca A. Haeusler et al. · 2019 · Journal of Clinical Investigation
Four Susceptibility Loci for Gallstone Disease Identified in a Meta-analysis of Genome-Wide Association Studies
Amit D. Joshi, Charlotte Andersson, Stephan Buch, Stefan Stender, Raymond Noordam, Lu-Chen C Weng, Peter Weeke, Paul Livermore Auer, Bernhard Otto Boehm, Constance Chen et al. · 2016 · Gastroenterology
High-Density Lipoprotein Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts
Majken K. Jensen, Sarah A. Aroner, Kenneth Jay Mukamal, Jeremy D. Furtado, Wendy S. Post, Michael Y. Tsai, Anne Marie Tjønneland, Joseph F. Polak, Eric B. Rimm, Kim Overvad et al. · 2017 · Circulation
National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk
Orringer, Carl E., Jacobson, Terry A., Maki, Kevin C. · 2019 · Journal of Clinical Lipidology
Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease
Elshazly, Mohamed B, Mani, Preethi, Nissen, Steven, Brennan, Danielle M, Clark, Donald, Martin, Seth, Jones, Steven R, Quispe, Renato, Donnellan, Eoin, Nicholls, Stephen J et al. · 2020 · European Journal of Preventive Cardiology
Reduction in lipoprotein-associated apoC-III levels following volanesorsen therapy: phase 2 randomized trial results
Yang, Xiaohong, Lee, Sang-Rok, Choi, Yun-Seok, Alexander, Veronica J., Digenio, Andres, Yang, Qingqing, Miller, Yury I., Witztum, Joseph L., Tsimikas, Sotirios · 2016 · Journal of Lipid Research
Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD
Marja‐Riitta Taskinen, Chris J. Packard, Jan Borén · 2019 · Current Atherosclerosis Reports
Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism
Bastian Ramms, Philip L.S.M. Gordts · 2018 · Current Opinion in Lipidology
Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production
Yanhong Guo, Yanbo Fan, Jifeng Zhang, Gwen Alyce Lomberk, Zhou Zhou, Lijie Sun, Angela Mathison, Minerva T. Garcia-Barrio, Ji Zhang, Lixia Zeng et al. · 2015 · Journal of Clinical Investigation
Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism
Reyes-Soffer, Gissette, Sztalryd, Carol, Horenstein, Richard B., Holleran, Stephen, Matveyenko, Anastasiya, Thomas, Tiffany, Nandakumar, Renu, Ngai, Colleen, Karmally, Wahida, Ginsberg, Henry N. et al. · 2019 · Arteriosclerosis, Thrombosis, and Vascular Biology
Glucagon-Like Peptide-2 Regulates Release of Chylomicrons From the Intestine
Satya Dash, Changting Xiao, Cecilia Morgantini, Philip W. Connelly, Bruce W. Patterson, Gary F. Lewis · 2014 · Gastroenterology
Targeting RNA With Antisense Oligonucleotides and Small Interfering RNA in Dyslipidemias
Katzmann, Julius L., Packard, Chris J., Chapman, M. John, Katzmann, Isabell, Laufs, Ulrich · 2020 · Journal of the American College of Cardiology
Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor?: New Insights From the Framingham Offspring Study
Bartlett, Jacquelaine, Predazzi, Irene M., Williams, Scott M., Bush, William S., Kim, Yeunjung, Havas, Stephen, Toth, Peter P., Fazio, Sergio, Miller, Michael · 2016 · Circulation: Cardiovascular Quality and Outcomes
Endocytosis of lipoproteins
Paolo Zanoni, Srividya Velagapudi, Mustafa Yalçınkaya, Lucia Rohrer, Arnold von Eckardstein · 2018 · Atherosclerosis
Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia
Bo Hu, Bo Li, Kun Li, Yuanyuan Liu, Chunhui Li, Lulu Zheng, Mengjie Zhang, Tongren Yang, Shuai Guo, Xiyu Dong et al. · 2022 · Science Advances
Dysfunctional high-density lipoproteins in coronary heart disease: implications for diagnostics and therapy
Annema, Wijtske, von Eckardstein, Arnold · 2016 · Translational Research
A new dawn for managing dyslipidemias: The era of rna-based therapies
Chiara Macchi, Cesare Riccardo Sirtori, Alberto Corsini, Raul Dias Santos, Gerald Francis Watts, Massimiliano Ruscica · 2019 · Pharmacological Research
Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding
Allan D. Sniderman, Patrick Couture, Seth Shay Martin, J DEGRAAF, Patrick R. Lawler, William C. Cromwell, John T. Wilkins, George Thanassoulis · 2018 · Journal of Lipid Research
Absolute 10-year risk of dementia by age, sex and APOE genotype: a population-based cohort study
Rasmussen, Katrine L., Tybjærg-Hansen, Anne, Nordestgaard, Børge G., Frikke-Schmidt, Ruth · 2018 · Canadian Medical Association Journal
HDL and Reverse Remnant-Cholesterol Transport (RRT): Relevance to Cardiovascular Disease
Anatol Kontush · 2020 · Trends in Molecular Medicine
The role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities
Derek M. Erion, Hyun‐Jun Park, Hui‐Young Lee · 2016 · BMB Reports
Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
Marja‐Riitta Taskinen, Jan Borén · 2016 · Current Atherosclerosis Reports
The Importance of Lipoprotein Lipase Regulation in Atherosclerosis
Anni Kumari, Kristian Kølby Kristensen, Michael Ploug, Anne-Marie Lund Winther · 2021 · Biomedicines
Triglyceride-rich lipoproteins and remnants: targets for therapy?
Dallinga-Thie, Geesje M., Kroon, Jeffrey, Borén, Jan, Chapman, M. John · 2016 · Current Cardiology Reports
Discovery and Optimization of Imidazopyridine-Based Inhibitors of Diacylglycerol Acyltransferase 2 (DGAT2)
Futatsugi, Kentaro, Kung, Daniel W., Orr, Suvi T. M., Cabral, Shawn, Hepworth, David, Aspnes, Gary, Bader, Scott, Bian, Jianwei, Boehm, Markus, Carpino, Philip A. et al. · 2015 · Journal of Medicinal Chemistry
Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort
Rasmussen, Katrine L, Tybjærg-Hansen, Anne, Nordestgaard, Børge G, Frikke-Schmidt, Ruth · 2019 · European Heart Journal
Fasting, non-fasting and postprandial triglycerides for screening cardiometabolic risk
Keirns, Bryant H., Sciarrillo, Christina M., Koemel, Nicholas A., Emerson, Sam R. · 2021 · Journal of Nutritional Science
Triglycerides on the rise: should we swap seats on the seesaw?
Libby, Peter · 2015 · European Heart Journal
The Treatment of Disorders of Lipid Metabolism
Klaus Georg Parhofer · 2016 · Deutsches Ärzteblatt international
Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia
Massimiliano Ruscica, Francesca Zimetti, Maria Pia Adorni, Cesare Riccardo Sirtori, Maria Giovanna Lupo, Nicola Ferri · 2020 · Pharmacological Research
Nonfasting Triglycerides, Low-Density Lipoprotein Cholesterol, and Heart Failure Risk: Two Cohort Studies of 113 554 Individuals
Varbo, Anette, Nordestgaard, Børge G. · 2018 · Arteriosclerosis, Thrombosis, and Vascular Biology
New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
Kyuho Kim, Henry N. Ginsberg, Sung Hee Choi · 2022 · Diabetes & Metabolism Journal
Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 (Apolipoprotein C3) and ANGPTL3 (Angiopoietin-Like Protein 3)
Henry N. Ginsberg, Ira J. Goldberg · 2022 · Arteriosclerosis Thrombosis and Vascular Biology
Genetic variation in the cholesterol transporter NPC1L1, ischaemic vascular disease, and gallstone disease
Bo Kobberø Lauridsen, Stefan Stender, Ruth Frikke‐Schmidt, Børge Grønne Nordestgaard, Anne Tybjærg‐Hansen · 2015 · European Heart Journal
Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products
Fialkow, Jonathan · 2016 · American Journal of Cardiovascular Drugs
Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes
Karin Åvall, Yusuf Ali, Ingo B. Leibiger, Barbara Leibiger, Tilo Moede, Meike Paschen, Andrea Dicker, Elisabetta Daré, Martin G. Köhler, Erwin Ilegems et al. · 2015 · Proceedings of the National Academy of Sciences
Association of Genetically Enhanced Lipoprotein Lipase–Mediated Lipolysis and Low-Density Lipoprotein Cholesterol–Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes
Lotta, Luca A., Stewart, Isobel D., Sharp, Stephen J., Day, Felix R., Burgess, Stephen, Luan, Jian’an, Bowker, Nicholas, Cai, Lina, Li, Chen, Wittemans, Laura B. L. et al. · 2018 · JAMA Cardiology
APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism
Antonina Giammanco, Rossella Spina, Angelo Baldassare Cefalu, Maurizio Rocco Averna · 2023 · Current Atherosclerosis Reports
Saroglitazar for the treatment of dyslipidemia in diabetic patients
Shashank Joshi · 2015 · Expert Opinion on Pharmacotherapy
Plasma Apolipoprotein C-III Levels, Triglycerides, and Coronary Artery Calcification in Type 2 Diabetics
Arman Qamar, Sumeet A. Khetarpal, Amit V. Khera, Atif Qasim, Daniel James Rader, Muredach P. Reilly · 2015 · Arteriosclerosis Thrombosis and Vascular Biology
Genetics of Lipid and Lipoprotein Disorders and Traits
Jacqueline S. Dron, Robert Alexander Hegele · 2016 · Current Genetic Medicine Reports
Cholesterol efflux capacity: An introduction for clinicians
Malcolm O. Anastasius, Maaike Kockx, Wendy Jessup, DAVID R. SULLIVAN, Kerry‐Anne Rye, Leonard Kritharides · 2016 · American Heart Journal
The Alzheimer's disease–protective CD33 splice variant mediates adaptive loss of function via diversion to an intracellular pool
Shoib Sarwar Siddiqui, Stevan A. Springer, Andrea Verhagen, Venkatasubramaniam Sundaramurthy, Frederico Alisson‐Silva, Weiping Jiang, Pradipta Ghosh, Ajit P Varki · 2017 · Journal of Biological Chemistry
The atherogenic dyslipidemia complex and novel approaches to cardiovascular disease prevention in diabetes
Stahel, Priska, Xiao, Changting, Hegele, Robert A., Lewis, Gary F. · 2018 · Canadian Journal of Cardiology
Plasma apolipoprotein E levels and risk of dementia: A Mendelian randomization study of 106,562 individuals
Rasmussen, Katrine L., Tybjærg‐Hansen, Anne, Nordestgaard, Børge G., Frikke‐Schmidt, Ruth · 2018 · Alzheimer's & Dementia
The impact of APOA5 , APOB , APOC3 and ABCA1 gene polymorphisms on ischemic stroke: Evidence from a meta-analysis
Anthony Au, Lyn Robyn Griffiths, Irene Looi, Cheah Wee Kooi, Loo Keat Wei · 2017 · Atherosclerosis
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia
Bergmark, Brian A., Marston, Nicholas A., Prohaska, Thomas A., Alexander, Veronica J., Zimerman, Andre, Moura, Filipe A., Kang, Yu Mi, Weinland, Julia, Murphy, Sabina A., Goodrich, Erica L. et al. · 2025 · New England Journal of Medicine
Impact of cardiovascular risk factors and genetics on 10-year absolute risk of dementia: risk charts for targeted prevention
Juul Rasmussen, Ida, Rasmussen, Katrine Laura, Nordestgaard, Børge G, Tybjærg-Hansen, Anne, Frikke-Schmidt, Ruth · 2020 · European Heart Journal
Impact of protein glycosylation on lipoprotein metabolism and atherosclerosis
Angela Pirillo, Monika Svecla, Alberico Luigi Catapano, Adriaan Georgius Holleboom, Giuseppe Danilo Norata · 2020 · Cardiovascular Research
Lipid Lowering Drugs: Present Status and Future Developments
Ruscica, Massimiliano, Ferri, Nicola, Santos, Raul D., Sirtori, Cesare R., Corsini, Alberto · 2021 · Current Atherosclerosis Reports
Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis
Baihui Zhang, Fan Yin, Ya-Nan Qiao, Shoudong Guo · 2022 · Frontiers in Molecular Biosciences
Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk
Julian C. van Capelleveen, Sophie J. Bernelot Moens, Xiaohong Yang, John J.P. Kastelein, Nicholas J. Wareham, Aeilko H. Zwinderman, Erik S.G. Stroes, Joseph Lee Witztum, G. Kees Hovingh, Kay‐Tee Khaw et al. · 2017 · Arteriosclerosis Thrombosis and Vascular Biology
Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic Study
Borén, Jan, Watts, Gerald F., Adiels, Martin, Söderlund, Sanni, Chan, Dick C., Hakkarainen, Antti, Lundbom, Jesper, Lundbom, Nina, Matikainen, Niina, Kahri, Juhani et al. · 2015 · Arteriosclerosis, Thrombosis, and Vascular Biology
New Therapeutic Approaches to the Treatment of Dyslipidemia
Daniel James Rader · 2016 · Cell Metabolism
Hypertriglyceridemia—causes, significance, and approaches to therapy
Santos-Baez, Leinys S., Ginsberg, Henry N. · 2020 · Frontiers in Endocrinology
Triglyceride-Rich Lipoproteins and Coronary Artery Disease Risk
Sumeet A. Khetarpal, Daniel James Rader · 2015 · Arteriosclerosis Thrombosis and Vascular Biology
Comparison of Five Major Guidelines for Statin Use in Primary Prevention in a Contemporary General Population
Martin Bødtker Mortensen, Børge Grønne Nordestgaard · 2018 · Annals of Internal Medicine
Triglycerides and triglyceride-rich lipoproteins in the development and progression of atherosclerosis
Giuliano Generoso, Carolina Castro Porto Silva Janovsky, Márcio Sommer Bittencourt · 2019 · Current Opinion in Endocrinology Diabetes and Obesity
Apoc2 loss-of-function zebrafish mutant as a genetic model of hyperlipidemia
Chao Liu, Keith P. Gates, Longhou Fang, Marcelo J. Amar, Dina A. Schneider, Honglian Geng, Wei Guo Huang, Jungsu Kim, Jennifer Pattison, Jian Zhang et al. · 2015 · Disease Models & Mechanisms
Body Mass Index and Risk of Alzheimer’s Disease: A Mendelian Randomization Study of 399,536 Individuals
Liv Tybjærg Nordestgaard, Anne Tybjærg‐Hansen, Børge Grønne Nordestgaard, Ruth Frikke‐Schmidt · 2017 · The Journal of Clinical Endocrinology & Metabolism
RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia
Gaudet, Daniel, Clifton, Peter, Sullivan, David, Baker, John, Schwabe, Christian, Thackwray, Susan, Scott, Russell, Hamilton, James, Given, Bruce, Melquist, Stacey et al. · 2023 · NEJM Evidence
Mendelian randomisation applied to drug development in cardiovascular disease: a review
Lauren E. Mokry, Omar S. Ahmad, Vincenzo Forgetta, George Thanassoulis, John Brent Richards · 2014 · Journal of Medical Genetics
Triglyceride metabolism and angiopoietin-like proteins in lipoprotein lipase regulation
Jing Li, Liang Li, Dongming Guo, Suyun Li, YuXin Zeng, Chu‐Hao Liu, Ru Fu, Mengqian Huang, Wei Xie · 2020 · Clinica Chimica Acta
Quinoa Seed Lowers Serum Triglycerides in Overweight and Obese Subjects: A Dose-Response Randomized Controlled Clinical Trial
Diana Navarro-Perez, Jessica Radcliffe, Audrey C. Tierney, Markandeya Jois · 2017 · Current Developments in Nutrition
Primary Prevention With Statins
Martin Bødtker Mortensen, Shoaib Afzal, Børge Grønne Nordestgaard, Erling Falk · 2015 · Journal of the American College of Cardiology
D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile
Sophie Valleix, Guglielmo Verona, Noémie Jourde‐Chiche, Brigitte Nédelec, Palma Patrizia Mangione, Frank Bridoux, Alain Mangé, Ahmet Doǧan, Jean‐Michel Goujon, Marie Lhomme et al. · 2016 · Nature Communications
The Role of Emerging Risk Factors in Cardiovascular Outcomes
Ben Lacey, William Guy Herrington, David Preiss, Sarah Lewington, Jane Armitage · 2017 · Current Atherosclerosis Reports
The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen General Population Study
Mortensen, Martin B., Afzal, Shoaib, Nordestgaard, Børge G., Falk, Erling · 2015 · European Heart Journal
APOE and dementia – resequencing and genotyping in 105,597 individuals
Rasmussen, Katrine L., Tybjærg‐Hansen, Anne, Nordestgaard, Børge G., Frikke‐Schmidt, Ruth · 2020 · Alzheimer's & Dementia
HDL cholesterol concentrations and risk of atherosclerotic cardiovascular disease – Insights from randomized clinical trials and human genetics
Emilie Westerlin Kjeldsen, Jesper Qvist Thomassen, Ruth Frikke‐Schmidt · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
The Copenhagen City Heart Study (Østerbroundersøgelsen)
Yasmine Aguib, Jassim M. S. Al Suwaidi · 2015 · Global Cardiology Science and Practice
Aggravated restenosis and atherogenesis in ApoCIII transgenic mice but lack of protection in ApoCIII knockouts: the effect of authentic triglyceride-rich lipoproteins with and without ApoCIII
Haibo Li, Yingchun Han, Rong Qi, Yuhui Wang, Xiaohong Zhang, Maomao Yu, Yin Tang, Mengyu Wang, Ya-Nan Shu, Wei Y. Huang et al. · 2015 · Cardiovascular Research
Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases
Werner J. Geldenhuys, Lin Li, Altaf S. Darvesh, Prabodh Sadana · 2016 · Drug Discovery Today
Lipoproteins in chronic kidney disease: from bench to bedside
Thimoteus Speer, Paul M. Ridker, Arnold von Eckardstein, Stefan J. Schunk, Danilo Fliser · 2020 · European Heart Journal
Triglyceride-lowering and anti-inflammatory mechanisms of omega-3 polyunsaturated fatty acids for atherosclerotic cardiovascular risk reduction
Qiyuan Keith Liu · 2021 · Journal of clinical lipidology
New Therapies for Lowering Triglyceride-Rich Lipoproteins
Robert S. Rosenson, Aleesha Shaik, Wen‐Liang Song · 2021 · Journal of the American College of Cardiology
Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia
Maki, Kevin C., Guyton, John R., Orringer, Carl E., Hamilton-Craig, Ian, Alexander, Dominik D., Davidson, Michael H. · 2016 · Journal of Clinical Lipidology
Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance
Chris J. Packard, Angela Pirillo, Sotirios Tsimikas, Brian A. Ference, Alberico Luigi Catapano · 2023 · Cardiovascular Research
Postprandial hypertriglyceridaemia revisited in the era of non-fasting lipid profile testing: a 2019 Expert Panel Statement, Main Text
Kolovou, Genovefa D., Watts, Gerald F., Mikhailidis, Dimitri P., Pérez-Martínez, Pablo, Mora, Samia, Bilianou, Helen, Panotopoulos, George, Katsiki, Niki, Ooi, Teik C., Lopez-Miranda, José et al. · 2019 · Current Vascular Pharmacology
ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study
Martin Bødtker Mortensen, Børge Grønne Nordestgaard, Shoaib Afzal, Erling Falk · 2016 · European Heart Journal
Triglycerides and residual risk
Antonio J. Vallejo‐Vaz, Pablo Corral, Laura Ester Schreier, Kausik Kumar Ray · 2020 · Current Opinion in Endocrinology Diabetes and Obesity
ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering Targets
Ioannis Akoumianakis, Evangelia Zvintzou, Kyriakos E. Kypreos, Theodosios D. Filippatos · 2021 · Current Atherosclerosis Reports
RNA-targeted therapeutics for lipid disorders
Sotirios Tsimikas · 2018 · Current Opinion in Lipidology
Triglycerides as a Shared Risk Factor between Dementia and Atherosclerotic Cardiovascular Disease: A Study of 125 727 Individuals
Liv Tybjærg Nordestgaard, Mette Christoffersen, Shoaib Afzal, Børge Grønne Nordestgaard, Anne Tybjærg‐Hansen, Ruth Frikke‐Schmidt · 2020 · Clinical Chemistry
Triglycerides: Emerging Targets in Diabetes Care? Review of Moderate Hypertriglyceridemia in Diabetes
Anastasia‐Stefania Alexopoulos, Ali Qamar, Kathryn Hutchins, Matthew J. Crowley, Bryan C. Batch, John R. Guyton · 2019 · Current Diabetes Reports
Association of Genetically Predicted Lipid Levels With the Extent of Coronary Atherosclerosis in Icelandic Adults
Eyþór Björnsson, Guðmar Þorleifsson, Anna Helgadóttir, Þórarinn Guðnason, Tómas Guðbjartsson, Karl K Andersen, Sólveig Grétarsdóttir, Ísleifur Ólafsson, Vinicius Tragante, Ólafur Ólafsson et al. · 2019 · JAMA Cardiology